After hepatitis C cure: follow-up and care

Current antiviral medicines cure hepatitis C in more than 95% of patients. Cure is confirmed when HCV RNA remains undetectable at least 12 weeks after treatment ends, known as a sustained virologic response. For the great majority of people, the virus does not return.

Follow-up after cure depends on how much liver damage was present before treatment. If there was no advanced fibrosis and no other liver condition, specialist hepatitis C follow-up is generally unnecessary. If cirrhosis was already present, lifelong surveillance must continue because the risk of liver cancer decreases but does not disappear.

How is cure confirmed?

The correct test is HCV RNA, also called viral load, at least 12 weeks after the final dose. A positive anti-HCV antibody cannot be used to confirm cure because the antibody usually remains positive for life even after the virus has gone.

An undetectable HCV RNA result confirms cure. Late relapse is exceptionally rare. When the virus appears again months or years later, it is often a new infection.

If you did not have cirrhosis

A person without advanced fibrosis, with normal liver tests and no other liver condition can return to routine health care. Periodic viral loads and special ultrasounds are not needed solely because of previous hepatitis C.

If liver enzymes remain elevated after cure, another cause should be sought, such as fatty liver, alcohol, medication, hepatitis B or autoimmune disease. Curing one virus does not automatically correct every liver problem.

If advanced fibrosis without cirrhosis (F3) was present before treatment, follow-up is individualized. Guidelines differ on surveillance in this group, so the fibrosis stage should be reviewed with a specialist before monitoring is stopped.

If you had cirrhosis or advanced fibrosis

People with cirrhosis need continued follow-up even when liver health improves. Care includes:

• Abdominal ultrasound every six months, generally with alpha-fetoprotein, to detect hepatocellular carcinoma early.
• Periodic assessment of platelets, liver function and signs of portal hypertension.
• Management of esophageal varices and other complications when needed.
• Continued control of weight, diabetes and alcohol intake.

Fibrosis may regress after cure, but liver cancer surveillance should not be stopped solely because an elastography result has improved.

Can I become infected again?

Yes. Cure does not provide immunity, and there is no vaccine against hepatitis C. Reinfection can occur after a new exposure to infected blood.

Risk increases when needles or injection equipment are shared, nonsterile equipment is used for tattoos or procedures, or certain sexual practices involve blood exposure. If exposure continues, HCV RNA testing is recommended at least once a year because the antibody will remain positive and can no longer detect a new infection.

Can I donate blood?

No. In routine practice, the history of hepatitis C and persistent antibody prevent blood donation even after cure. This does not mean that you remain contagious in daily life.

Care after treatment

Maintain a healthy weight, limit or avoid alcohol, and review any supplement use with your clinician. Vaccination against hepatitis A and hepatitis B may be appropriate if you are not immune.

Curing hepatitis C greatly improves the outlook. Follow-up is not the same for everyone. It is determined by the scar tissue left by the infection and any other factors that may continue to injure the liver.

See also

• Hepatitis C
• Hepatitis C frequently asked questions
• Cirrhosis
• Hepatocellular carcinoma